Eye drops work by delivering active ingredients through a thin, transparent layer of tissue on the front of your eye called the cornea. When a drop lands on your eye’s surface, the medication dissolves into the tear film and permeates through the cornea (or through the surrounding white tissue) to reach deeper structures. The specific effect depends entirely on what’s in the drop: lubricants coat and protect the surface, antihistamines block allergic reactions, and medicated drops for conditions like glaucoma alter fluid pressure inside the eye.
What surprises most people is how inefficient the process is. Less than 5% of the medication in a typical eye drop actually gets absorbed. The rest is washed away by blinking within about 15 to 30 seconds or drained through a tiny channel in the inner corner of your eye that connects to your nose and throat.
How the Eye Absorbs Medication
The cornea is the primary gateway. It’s made up of several layers, and drugs pass through them at different rates depending on whether the molecule dissolves better in water or fat. This is why eye drop formulations are so carefully engineered: the drug needs to be soluble enough to mix with your tears but also capable of crossing fatty cell membranes in the cornea.
There’s also a secondary route. Some drugs penetrate through the conjunctiva, the thin membrane covering the white of your eye, and then pass through the sclera (the white outer shell) to reach internal structures. This noncorneal pathway is especially important for larger drug molecules that don’t cross the cornea easily. Once inside, the medication circulates through the aqueous humor, the clear fluid filling the front chamber of the eye, and reaches its target tissue.
Lubricating Drops for Dry Eyes
Artificial tears don’t deliver a drug so much as replace or reinforce your natural tear film. The key ingredient in most over-the-counter lubricating drops is a viscosity agent, with carboxymethylcellulose being the most common in the United States. It binds directly to the surface cells of your cornea and stays there, increasing the thickness and stability of the moisture layer so it doesn’t evaporate as quickly. The thicker the formulation, the longer it lingers, which is why gel-based drops last longer but can temporarily blur your vision.
Many formulations also include humectants like glycerin, which pull water molecules toward the eye’s surface and hold them there. Glycerin does double duty: beyond moisture retention, it promotes the growth of surface cells and protects them from the damage that occurs when tears become too salty, a common problem in chronic dry eye. This is why consistent use of artificial tears can gradually improve the health of the eye’s surface, not just relieve symptoms in the moment.
Redness-Relief Drops
When your eyes look red, you’re seeing dilated blood vessels on the surface. Redness-relief drops contain ingredients that activate receptors on the tiny muscles surrounding those blood vessels, causing the muscles to contract and the vessels to narrow. Less blood flow near the surface means less visible redness.
The catch is rebound redness. With regular use, the blood vessels adapt to being artificially constricted. When the drop wears off, they dilate even more than they did before, making your eyes look redder than when you started. This creates a cycle where you feel like you need the drops more and more often. Common side effects of these drops also include local irritation and burning. For occasional cosmetic use they’re fine, but they don’t treat the underlying cause of redness.
Allergy Drops
Allergic eye symptoms like itching, swelling, and watering happen because your immune system releases histamine in response to pollen, pet dander, or other triggers. Histamine binds to receptors on cells in your eye and triggers inflammation. Allergy eye drops interrupt this process in one of two ways, and many modern drops do both simultaneously.
Antihistamine drops compete with histamine for the same receptor sites on your cells. When the drug molecule occupies the receptor instead of histamine, the inflammatory signal never fires. This is why they relieve itching within minutes.
Mast cell stabilizers take a different, more preventive approach. Mast cells are the immune cells that store and release histamine in the first place. These drops block calcium from entering mast cells, which prevents them from breaking open and dumping their histamine payload. This is why doctors sometimes recommend starting allergy drops before pollen season begins: if you can keep mast cells stable, the allergic cascade never gets started.
Several popular over-the-counter allergy drops combine both mechanisms in one formula, giving you immediate itch relief from the antihistamine effect while the mast cell stabilizer prevents the next wave of symptoms.
Why Most of the Drop Never Reaches Your Eye
A standard eye drop is about 30 to 50 microliters of liquid, but the natural pocket between your lower eyelid and eyeball (called the cul-de-sac) holds only about 7 to 10 microliters comfortably. It can stretch to around 30 microliters temporarily, but reflex blinking kicks in almost immediately and pushes the excess out. Within 15 to 30 seconds, most of the drug has been swept away.
A significant portion also drains through the nasolacrimal duct, the tiny opening at the inner corner of your eye that funnels tears down into your nasal passages. This is why you sometimes taste eye drops in the back of your throat. It’s also why some medicated drops can cause systemic side effects: the drug absorbs through the mucous membranes of your nose and enters your bloodstream.
You can improve absorption with a simple technique. After placing a drop, gently close your eyes and press a fingertip against the inner corner of your eye (right next to your nose) for one to two minutes. This blocks the drainage duct and keeps the medication pooled on the eye’s surface longer, giving it more time to penetrate the cornea.
The Preservative Problem
Most multi-dose eye drop bottles contain preservatives to prevent bacterial contamination, and the most common one is benzalkonium chloride, or BAK. It’s effective at killing microbes, dissolves easily in water, and is inexpensive. But it comes with a tradeoff.
BAK damages cells on the eye’s surface by disrupting their mitochondria, the energy-producing structures inside every cell. At the concentrations found in commercial eye drops, BAK can inhibit cellular energy production by over 90%. With occasional use, your eye repairs this damage quickly. But with long-term daily use, particularly for chronic conditions like glaucoma where you’re applying drops every day for years, the cumulative effect can cause or worsen dry eye, trigger inflammation, and damage tissue inside the eye.
Clinical trials comparing BAK-containing drops to preservative-free versions have found measurable inflammation inside the eye after just one month of exposure. This is why preservative-free formulations, which come in single-use vials instead of multi-dose bottles, are increasingly recommended for anyone using eye drops more than a few times a day or over extended periods.
Sustained-Release Alternatives to Daily Drops
Because daily eye drops are so inefficient and depend on patients remembering to use them correctly, a new generation of sustained-release devices is entering the market. These are designed primarily for glaucoma, where consistent drug delivery is critical to preventing vision loss.
One approach uses tiny implants placed inside the eye during a brief procedure. A titanium reservoir about the size of a grain of rice sits in the eye’s drainage tissue and releases medication through a nanoporous membrane for months at a time. In clinical trials of one such implant, 81% of patients remained medication-free at 12 months, with no need for daily drops at all.
Another option is a drug-loaded punctal plug, a small device placed in the tear drainage opening at the inner corner of the eye. It slowly releases medication directly onto the eye’s surface, mimicking the effect of drops without requiring you to remember them. Biodegradable rod-shaped implants that release medication over six months are also in development, designed to dissolve naturally so no removal procedure is needed.
These technologies address both the bioavailability problem (getting more drug to the right place) and the compliance problem (the reality that many people forget doses or apply drops incorrectly). For conditions requiring years of daily treatment, they represent a meaningful shift in how eye medication is delivered.